Related Experiment Video
Updated: Dec 6, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Thrombocytopenia associated with transcatheter closure of giant patent ductus arteriosus
Lei Liu1,2, Peng Yue1,2, Xiaolan Zheng1,2
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Insights
A high occluder size to body weight ratio (≥1.6) predicts thrombocytopenia after giant patent ductus arteriosus closure. This ratio also predicts longer hospital stays, with medication offering no benefit.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Thrombocytopenia is a known complication after giant patent ductus arteriosus (PDA) closure.
- Risk factors for post-procedural thrombocytopenia remain under-researched.
Purpose of the Study:
- To identify risk factors for thrombocytopenia following PDA closure.
- To determine predictors of hospitalization duration after PDA closure.
Main Methods:
- Retrospective review of patients undergoing PDA closure with large occluders (≥10/12 mm) from January 2013 to June 2019.
- Analysis of patient characteristics and follow-up data.
- Univariate analysis, ROC curves, and linear regression to identify risk factors and predictors.
Main Results:
- Thrombocytopenia occurred in 17.5% of patients (32/183).
- The ratio of occluder disc size to body weight was an independent predictor of thrombocytopenia (AUC=0.691, p=0.001).
- A ratio > 1.5895 indicated higher risk; each unit increase predicted ~2.86 additional hospitalization days.
Conclusions:
- A ratio of occluder size to body weight > 1.6 is associated with guaranteed thrombocytopenia.
- Increased ratio correlates with extended hospitalization; medication does not shorten stay or improve platelet count.
Introduction:
Thrombocytopenia occasionally occurs following the closure of some giant patent ductus arteriosus cases. Unfortunately, there is no associated research describing the associated risk factors for thrombocytopenia post-procedure.
Methods:
We reviewed all patients who received occluders with sizes ≥10/12 mm between January 2013 and June 2019. All the data and information on the characteristics of the patients and their follow-up were recorded. Univariate analysis, receiver operating characteristic curves, and linear regression were used to analyse the risk factors for thrombocytopenia and the predictors of hospitalisation stay.
Results:
Finally, 32 patients (17.5%) suffered from thrombocytopenia. Univariate analysis revealed the ratio between occluder disc size (mm) and body weight (kg) (1.71 ± 0.51 versus 1.35 ± 0.53) as an independent predictive factor for thrombocytopenia, and the area under the curve of the ratio of occluder size and body weight for predicting thrombocytopenia post-closure was 0.691 (95% confidence interval: 0.589-0.792, p = 0.001). The best cut-off value for the ratio of occluder size and weight was 1.5895, with a sensitivity and specificity of 68.8 and 66.9%, respectively. Each unit of the ratio of occluder size and body weight predicted an average hospitalisation stay of 2.856 days (95% confidence interval: 1.380-4.332). Treatment with medication did not reduce the hospitalisation stay or benefit platelet restoration.
Conclusion:
Once the ratio of occluder size and body weight is greater than 1.6, thrombocytopenia always exists. Every unit of the ratio of occluder size and body weight represents an additional 3 days of hospitalisation. Treatment does not reduce the duration of hospitalisation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Aneurysm III: Interprofessional Care

